Sumana Devata - University of Michigan

基本信息

浏览量：7

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 63 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Split-Dose R-CHOP for Older Patients with Treatment Naïve DLBCL

Adam Kidwell,Fateeha Furqan,Emilie Aschenbrenner,Walter Longo,Sumana Devata,Mehdi Hamadani, Timothy S. Fenske, Nirav N. Shah

Bloodno. Supplement 1 (2024): 2374-2374

引用0浏览0引用

Evaluation of AZD0486, a Novel CD19xCD3 T-Cell Engager, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in an Ongoing First-in-Human Phase 1 Study: High Complete Responses Seen in CAR-T-Naive and CAR-T-Exposed Patients

Sameh Gaballa,Jing-Zhou Hou,Sumana Devata, Seok-Goo Cho, Ranjit Nair, Dok Hyun Yoon, Ryan Jacobs, Koji Izutsu,Don A. Stevens,Dai Maruyama, Constantine S. Tam,Yazeed Sawalha,Aravind Ramakrishnan, Matthew Matasar, Denise Brennan, Sue Zhu, Robin Lesley, Yasuhiro Oki,David Sermer, Tae Min Kim

Bloodno. Supplement 1 (2024): 868-868

引用0浏览0引用

CNS Status at Diagnosis Can Identify Acute Myeloid Leukemia Patients with Poor Induction Outcomes

Kristine Broge-Reynen,Emily Giever,Aniko Szabo, Ryan Conrardy, Nicole M Held, Laura C. Michaelis,Lyndsey Runaas, Sameem Abedin, Guru Subramanian Guru Murthy, Karen-Sue Carlson, Ravi Kishore Narra,Sumana Devata,Sheila Swartz, Valarie Ehrlich, Mary Rodgers, Allison Johnson, Ehab L. Atallah

Bloodno. Supplement 1 (2024): 5173-5173

引用0浏览0引用

Double Step-up Dosing (2SUD) Regimen Mitigates Severe Icans and CRS While Maintaining High Efficacy in Subjects with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL) Treated with AZD0486, a Novel CD19xCD3 T-Cell Engager (TCE): Updated Safety and Efficacy Data from the Ongoing First-in-Human (FIH) Phase 1 Trial